The CEO of India's Stelis Biopharma stepped down days after it announced a deal to manufacturer at least 200 million doses of Russia’s coronavirus vaccine https://t.co/5Q7N6X7XQj
— Bloomberg (@business) April 21, 2021
Source: Twitter
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.